CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Tempus targets $1.595B-$1.605B 2026 revenue as it outlines 2028 $400M uplift tied to xT CDx and xF

EarningsxT CDxxFPositive
AI Analysis

Summary

Tempus provided 2026 revenue guidance of $1.595B-$1.605B and outlined plans for a $400M revenue uplift by 2028 tied to xT CDx and xF platforms.

Financial Highlights

Revenue

$1.595B-$1.605B 2026 guidance with $400M uplift targeted for 2028

Guidance

$1.595B-$1.605B 2026 revenue; $400M uplift expected by 2028 from xT CDx and xF

Importance:5/10
Sentiment:
0.60
revenue guidancexT CDxxF2026 outlook2028 targets
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 30, 2026 10:34 PM

Read Original